The use of drug based on technologically processed antibodie — 2021 Double Blind Clinical Trial | BudProfiles
PositiveDouble Blind Clinical Trial2021
The use of drug based on technologically processed antibodies to endocannabinoid receptor type 1 in the treatment of obesity in adults: results of a multicenter double blind placebo controlled randomized clinical trial